Newborn Screening for Sickle Cell Disease in the Caribbean: An Update of the Present Situation and of the Disease Prevalence

The region surrounding the Caribbean Sea is predominantly composed of island nations for its Eastern part and the American continental coast on its Western part. A large proportion of the population, particularly in the Caribbean islands, traces its ancestry to Africa as a consequence of the Atlantic slave trade during the XVI–XVIII centuries. As a result, sickle cell disease has been largely introduced in the region. Some Caribbean countries and/or territories, such as Jamaica and the French territories, initiated newborn screening (NBS) programs for sickle cell disease more than 20 years ago. They have demonstrated the major beneficial impact on mortality and morbidity resulting from early childhood care. However, similar programs have not been implemented in much of the region. This paper presents an update of the existing NBS programs and the prevalence of sickle cell disease in the Caribbean. It demonstrates the impact of the Caribbean Network of Researchers on Sickle Cell Disease and Thalassemia (CAREST) on the extension of these programs. The presented data illustrate the importance of advocacy in convincing policy makers of the feasibility and benefit of NBS for sickle cell disease when coupled to early care.

[1]  Marie-Dominique Hardy-Dessources,et al.  Point‐of‐care screening for sickle cell disease in low‐resource settings: A multi‐center evaluation of HemoTypeSC, a novel rapid test , 2018, American journal of hematology.

[2]  D. Weatherall,et al.  Sickle cell disease , 2018, Nature Reviews Disease Primers.

[3]  Ketty Lee,et al.  Prevalence of sickle cell disease among Grenadian newborns , 2018, Journal of medical screening.

[4]  J. Kanter,et al.  Newborn Screening for Sickle Cell Disease in St. Vincent and the Grenadines: Results of a Pilot Newborn Screening Program , 2017, Global pediatric health.

[5]  C. Hoppe,et al.  The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologies. , 2017, Blood cells, molecules & diseases.

[6]  V. Elias,et al.  Knowledge of and attitudes toward heel prick screening for sickle cell disease in Saint Lucia , 2017, Revista panamericana de salud publica = Pan American journal of public health.

[7]  M. Nwegbu,et al.  Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN™) in Screening for Sickle Cell Disease , 2017, Hemoglobin.

[8]  E. Svarch,et al.  Atención de urgencia al paciente adulto con drepanocitosis en el Instituto de Hematología e Inmunología , 2017 .

[9]  E. Svarch Program for comprehensive sickle cell disease care in Cuba , 2016 .

[10]  C. Quinn,et al.  A rapid, inexpensive and disposable point‐of‐care blood test for sickle cell disease using novel, highly specific monoclonal antibodies , 2016, British journal of haematology.

[11]  J. Knight-Madden,et al.  CAREST--Multilingual Regional Integration for Health Promotion and Research on Sickle Cell Disease and Thalassemia. , 2016, American journal of public health.

[12]  J. Herrick,et al.  Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. , 2014, JAMA.

[13]  I. Hambleton,et al.  Clinical findings associated with homozygous sickle cell disease in the Barbadian population – do we need a national SCD registry? , 2014, BMC Research Notes.

[14]  G. Barreto,et al.  Frequency and origin of haplotypes associated with the beta-globin gene cluster in individuals with trait and sickle cell anemia in the Atlantic and Pacific coastal regions of Colombia , 2013, Genetics and molecular biology.

[15]  M. Etienne‐Julan,et al.  Universal newborn screening for haemoglobinopathies in Guadeloupe (French West Indies): A 27-year experience , 2013, Journal of medical screening.

[16]  S. Rotz,et al.  Prevalence of sickle cell disease, hemoglobin S, and hemoglobin C among Haitian newborns , 2013, American journal of hematology.

[17]  D. Acuña-Castroviejo,et al.  β‐globin gene cluster haplotypes in sickle cell patients from Panamá , 2011, American journal of human biology : the official journal of the Human Biology Council.

[18]  P. Jayakar,et al.  Expanded newborn screening in Puerto Rico and the US Virgin Islands: education and barriers assessment , 2009, Genetics in Medicine.

[19]  M. Saborío,et al.  [Abnormal haemoglobins in the newborn human population of Costa Rica]. , 2008, Revista de Biología Tropical.

[20]  M. Reid,et al.  Newborn sickle cell disease screening: the Jamaican experience (1995–2006) , 2007, Journal of medical screening.

[21]  Manuel Saborío,et al.  Hemoglobinas anormales en la población neonatal de Costa Rica , 2007 .

[22]  L. Heredero-Baute Community-Based Program for the Diagnosis and Prevention of Genetic Disorders in Cuba , 2004, Public Health Genomics.

[23]  J. Herrick,et al.  Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910. , 2001, The Yale journal of biology and medicine.

[24]  A. Arends,et al.  Determination of β‐globin gene cluster haplotypes and prevalence of α‐thalassemia in sickle cell anemia patients in Venezuela , 2000 .

[25]  A. Froger,et al.  Diverse Genetic Mechanisms Operate to Generate Atypical βs Haplotypes in the Population of Guadeloupe , 2000, Hemoglobin.

[26]  A. Arends,et al.  Determination of beta-globin gene cluster haplotypes and prevalence of alpha-thalassemia in sickle cell anemia patients in Venezuela. , 2000, American journal of hematology/oncology.

[27]  G. Merault,et al.  Sickle cell disorder, β‐globin gene cluster haplotypes and α‐thalassemia in neonates and adults from Guadeloupe , 1997 .

[28]  G. Merault,et al.  Sickle cell disorder, beta-globin gene cluster haplotypes and alpha-thalassemia in neonates and adults from Guadeloupe. , 1997, American journal of hematology.

[29]  D. Higgs,et al.  Haemoglobin gene frequencies in the Jamaican population: a study in 100,000 newborns , 1986, British journal of haematology.